User menu

Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response.

Bibliographic reference Ercolini, Anne M ; Ladle, Brian H ; Manning, Elizabeth A ; Pfannenstiel, Lukas W ; Armstrong, Todd D ; et. al. Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response.. In: The Journal of Experimental Medicine, Vol. 201, no. 10, p. 1591-602 (2005)
Permanent URL
  1. Sprent Jonathan, Webb Susan R, Intrathymic and extrathymic clonal deletion of T cells, 10.1016/0952-7915(95)80004-2
  2. Sprent Jonathan, Kishimoto Hidehiro, The thymus and negative selection, 10.1034/j.1600-065x.2002.18512.x
  3. Öhlén Claes, Kalos Michael, Hong Doley J., Shur Aaron C., Greenberg Philip D., Expression of a Tolerizing Tumor Antigen in Peripheral Tissue Does Not Preclude Recovery of High-Affinity CD8 + T Cells or CTL Immunotherapy of Tumors Expressing the Antigen , 10.4049/jimmunol.166.4.2863
  4. Adler Adam J., Marsh David W., Yochum Gregory S., Guzzo James L., Nigam Ankesh, Nelson William G., Pardoll Drew M., CD4+T Cell Tolerance to Parenchymal Self-Antigens Requires Presentation by Bone Marrow–derived Antigen-presenting Cells, 10.1084/jem.187.10.1555
  5. de Visser K. E., Cordaro T. A., Kessels H. W. H. G., Tirion F. H., Schumacher T. N. M., Kruisbeek A. M., Low-Avidity Self-Specific T Cells Display a Pronounced Expansion Defect That Can Be Overcome by Altered Peptide Ligands, 10.4049/jimmunol.167.7.3818
  6. Oncogene., 20;18, 5249 (1999)
  7. Guy C. T., Webster M. A., Schaller M., Parsons T. J., Cardiff R. D., Muller W. J., Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease., 10.1073/pnas.89.22.10578
  8. Cancer Res., 60, 3569 (2000)
  9. Cancer Res., 61, 3689 (2001)
  10. North R. J., Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells, 10.1084/jem.155.4.1063
  11. Hoover Shelley K., Barrett Sandra K., Turk Thomas M. T., Lee Te-Chung, Bear Harry D., Cyclophosphamide and abrogation of tumor-induced suppressor T cell activity, 10.1007/bf01742376
  12. Ghiringhelli François, Larmonier Nicolas, Schmitt Elise, Parcellier Arnaud, Cathelin Dominique, Garrido Carmen, Chauffert Bruno, Solary Eric, Bonnotte Bernard, Martin François, CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative, 10.1002/eji.200324181
  14. J. Exp. Med., 20;200, 771 (2004)
  15. Thornton Angela M., Shevach Ethan M., CD4+CD25+Immunoregulatory T Cells Suppress Polyclonal T Cell Activation In Vitro by Inhibiting Interleukin 2 Production, 10.1084/jem.188.2.287
  16. Hori S., Control of Regulatory T Cell Development by the Transcription Factor Foxp3, 10.1126/science.1079490
  17. Ercolini A. M., Machiels J.-P. H., Chen Y. C., Slansky J. E., Giedlen M., Reilly R. T., Jaffee E. M., Identification and Characterization of the Immunodominant Rat HER-2/neu MHC Class I Epitope Presented by Spontaneous Mammary Tumors from HER-2/neu-Transgenic Mice, 10.4049/jimmunol.170.8.4273
  18. Lee D. R., The murine MHC class I genes, H-2Dq and H-2Lq, are strikingly homologous to each other, H-2Ld, and two genes reported to encode tumor- specific antigens, 10.1084/jem.168.5.1719
  19. Savage Peter A, Boniface J.Jay, Davis Mark M, A Kinetic Basis For T Cell Receptor Repertoire Selection during an Immune Response, 10.1016/s1074-7613(00)80048-5
  20. Cawthon A. G., Lu H., Alexander-Miller M. A., Peptide Requirement for CTL Activation Reflects the Sensitivity to CD3 Engagement: Correlation with CD8   Versus CD8   Expression, 10.4049/jimmunol.167.5.2577
  21. Walker Lucy S.K., Chodos Anna, Eggena Mark, Dooms Hans, Abbas Abul K., Antigen-dependent Proliferation of CD4+CD25+Regulatory T Cells In Vivo, 10.1084/jem.20030315
  22. Cancer Res., 59, 3128 (1999)
  23. Nugent C. T., Morgan D. J., Biggs J. A., Ko A., Pilip I. M., Pamer E. G., Sherman L. A., Characterization of CD8+ T Lymphocytes That Persist After Peripheral Tolerance to a Self Antigen Expressed in the Pancreas, 10.4049/jimmunol.164.1.191
  24. O'Garra Anne, Vieira Paulo, Regulatory T cells and mechanisms of immune system control, 10.1038/nm0804-801
  25. Lustgarten Joseph, Dominguez Ana Lucia, Cuadros Camilo, The CD8+ T cell repertoire against Her-2/neu antigens in neu transgenic mice is of low avidity with antitumor activity, 10.1002/eji.200324427
  26. Busch Dirk H., Pamer Eric G., T Cell Affinity Maturation by Selective Expansion during Infection, 10.1084/jem.189.4.701
  27. Alexander-Miller M. A., Leggatt G. R., Berzofsky J. A., Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy., 10.1073/pnas.93.9.4102
  28. Dutoit V., Rubio-Godoy V., Doucey M.-A., Batard P., Lienard D., Rimoldi D., Speiser D., Guillaume P., Cerottini J.-C., Romero P., Valmori D., Functional Avidity of Tumor Antigen-Specific CTL Recognition Directly Correlates with the Stability of MHC/Peptide Multimer Binding to TCR, 10.4049/jimmunol.168.3.1167
  29. Cancer Res., 61, 5850 (2001)
  30. J. Immunol., 162, 2227 (1999)
  31. Yang S., Linette G. P., Longerich S., Haluska F. G., Antimelanoma Activity of CTL Generated from Peripheral Blood Mononuclear Cells After Stimulation with Autologous Dendritic Cells Pulsed with Melanoma gp100 Peptide G209-2M Is Correlated to TCR Avidity, 10.4049/jimmunol.169.1.531
  32. J. Immunol., 162, 989 (1999)
  33. Antony P. A., Piccirillo C. A., Akpinarli A., Finkelstein S. E., Speiss P. J., Surman D. R., Palmer D. C., Chan C.-C., Klebanoff C. A., Overwijk W. W., Rosenberg S. A., Restifo N. P., CD8+ T Cell Immunity Against a Tumor/Self-Antigen Is Augmented by CD4+ T Helper Cells and Hindered by Naturally Occurring T Regulatory Cells, 10.4049/jimmunol.174.5.2591
  34. Yang Yiping, Huang Ching-Tai, Huang Xiaopei, Pardoll Drew M, Persistent Toll-like receptor signals are required for reversal of regulatory T cell–mediated CD8 tolerance, 10.1038/ni1059
  35. Pardoll Drew, DOES THE IMMUNE SYSTEM SEE TUMORS AS FOREIGN OR SELF?, 10.1146/annurev.immunol.21.120601.141135
  36. Int. J. Oncol., 12, 161 (1998)
  37. Hernandez J., Lee P. P., Davis M. M., Sherman L. A., The Use of HLA A2.1/p53 Peptide Tetramers to Visualize the Impact of Self Tolerance on the TCR Repertoire, 10.4049/jimmunol.164.2.596
  38. Derby Michael A., Wang Jian, Margulies David H., Berzofsky Jay A., Two intermediate-avidity cytotoxic T lymphocyte clones with a disparity between functional avidity and MHC tetramer staining, 10.1093/intimm/13.6.817
  39. Rubio-Godoy V., Dutoit V., Rimoldi D., Lienard D., Lejeune F., Speiser D., Guillaume P., Cerottini J.-C., Romero P., Valmori D., Discrepancy between ELISPOT IFN-  secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life, 10.1073/pnas.181348898
  40. Kreuwel H. T. C., Biggs J. A., Pilip I. M., Pamer E. G., Lo D., Sherman L. A., Defective CD8+ T Cell Peripheral Tolerance in Nonobese Diabetic Mice, 10.4049/jimmunol.167.2.1112
  41. Heath William R., Kurts Christian, Miller Jacques F.A.P., Carbone Francis R., Cross-tolerance: A Pathway for Inducing Tolerance to Peripheral Tissue Antigens, 10.1084/jem.187.10.1549
  42. Sakaguchi Shimon, Sakaguchi Noriko, Shimizu Jun, Yamazaki Sayuri, Sakihama Toshiko, Itoh Misako, Kuniyasu Yuhshi, Nomura Takashi, Toda Masaaki, Takahashi Takeshi, Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance, 10.1034/j.1600-065x.2001.1820102.x
  43. Altman J. D., Moss P. A. H., Goulder P. J. R., Barouch D. H., McHeyzer-Williams M. G., Bell J. I., McMichael A. J., Davis M. M., Phenotypic Analysis of Antigen-Specific T Lymphocytes, 10.1126/science.274.5284.94
  44. Disis Mary L., Cheever Martin A., HER-2/neu Protein: A Target for Antigen-Specific Immunotherapy of Human Cancer, Advances in Cancer Research (1997) ISBN:9780120066711 p.343-371, 10.1016/s0065-230x(08)60103-7
  45. Novellino Luisa, Castelli Chiara, Parmiani Giorgio, A listing of human tumor antigens recognized by T cells: March 2004 update, 10.1007/s00262-004-0560-6
  46. Hernandez J., Ko A., Sherman L. A., CTLA-4 Blockade Enhances the CTL Responses to the p53 Self-Tumor Antigen, 10.4049/jimmunol.166.6.3908
  47. J. Immunol., 160, 643 (1998)
  48. Liu George Y., Fairchild Paul J., Smith Richard M., Prowle John R., Kioussis Dimitris, Wraith David C., Low avidity recognition of self-antigen by T cells permits escape from central tolerance, 10.1016/1074-7613(95)90170-1